Drug Pipeline

Opdivo® Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-19 NCT06948448
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®…		 Trial sites expanded: 28 -> 33 locations
Active Studies by Phase
Phase 2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06948448 A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®… Colorectal Cancer Recruiting
Phase 1
NCT07176650 Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and… Hepatocellular Carcinoma (HCC) Recruiting
NCT07476326 Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as… Melanoma Not Yet Recruiting
NCT07518043 A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors Esophageal and/or Cardia Cancer Not Yet Recruiting
Sponsors Running Opdivo® Trials
Shanghai Henlius Biotech (2) Ono Pharmaceutical Co., Ltd. (1) Biocon Biologics UK PLC (1)
Disease Areas
Melanoma (2) Colorectal Cancer (1) Liver Cancer (1) Bladder Cancer (1)
Get alerts when Opdivo® trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free